Literature DB >> 3418699

Mutational analysis of the tRNA mimicry of brome mosaic virus RNA. Sequence and structural requirements for aminoacylation and 3'-adenylation.

T W Dreher1, T C Hall.   

Abstract

The genomic RNAs of brome mosaic virus (BMV) exhibit various tRNA-like properties, including specific tyrosylation by tyrosyl-tRNA synthetases and adenylation of the 3'-CCOH derivative by tRNA nucleotidyl transferases. We have studied the effect of numerous mutations in all domains of the tRNA-like structure of BMV RNA on tyrosylation and adenylation in vitro. Surprisingly few mutations resulted in more than 50% decrease in tyrosylation rates with either wheat germ or yeast synthetases; those mutations were at the 3' terminus, the pseudoknot, and the bases of arms B and E. The results suggest an interaction of synthetase with arm A as the analog of the aminoacyl acceptor stem of tRNAs, and arm B as the analog of the anticodon arm of tRNAs, although there is no apparent interaction with the terminal loop of arm B analogous to the interaction with the anticodon in tRNAs. Mutations at several loci resulted in large losses of adenylation activity catalyzed by wheat germ and Escherichia coli nucleotidyl transferases; those loci were the pseudoknot, the bases of arms B, C and D, and at the junctions of these arms with arm A. These studies have identified mutants specifically defective in one of the tRNA-like activities, which are appropriate for investigating the role of these activities during infection in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418699     DOI: 10.1016/0022-2836(88)90437-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  27 in total

1.  Efficient mischarging of a viral tRNA-like structure and aminoacylation of a minihelix containing a pseudoknot: histidinylation of turnip yellow mosaic virus RNA.

Authors:  J Rudinger; C Florentz; T Dreher; R Giegé
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

2.  Contributions of the brome mosaic virus RNA-3 3'-nontranslated region to replication and translation.

Authors:  F C Lahser; L E Marsh; T C Hall
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 3.  RNA pseudoknots that interact with components of the translation apparatus.

Authors:  P Schimmel
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

4.  Mutational analysis of the central domain of adenovirus virus-associated RNA mandates a revision of the proposed secondary structure.

Authors:  T Pe'ery; K H Mellits; M B Mathews
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  tRNA elements mediate the assembly of an icosahedral RNA virus.

Authors:  Yoon Gi Choi; Theo W Dreher; A L N Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

6.  The valine anticodon and valylatability of Peanut clump virus RNAs are not essential but provide a modest competitive advantage in plants.

Authors:  D Matsuda; P Dunoyer; O Hemmer; C Fritsch; T W Dreher
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Single-Molecule FRET Reveals Three Conformations for the TLS Domain of Brome Mosaic Virus Genome.

Authors:  Mario Vieweger; Erik D Holmstrom; David J Nesbitt
Journal:  Biophys J       Date:  2015-12-15       Impact factor: 4.033

8.  Template sequence near the initiation nucleotide can modulate brome mosaic virus RNA accumulation in plant protoplasts.

Authors:  M Hema; C Cheng Kao
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Recombination and polymerase error facilitate restoration of infectivity in brome mosaic virus.

Authors:  A L Rao; T C Hall
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Requirement for a viral trans-acting factor encoded by brome mosaic virus RNA-2 provides strong selection in vivo for functional recombinants.

Authors:  A L Rao; T C Hall
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.